Reactive hyperaemic index

Biomarker

1 paper2 findings

  • Human trial1

Interventions

2

Empagliflozin

no changein humans1

1 study
  1. Empagliflozin has no effect on reactive hyperaemic index in humans.

    Human trialtype 2 diabetes32-weekn = 120

    Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial

    Journal of diabetes and its complications29 Aug 2026

More on Empagliflozin

Semaglutide

no changein humans1

1 study
  1. Semaglutide has no effect on reactive hyperaemic index in humans (0.11, 95%CI [-0.04;0.24], p = 0.16).

    Human trialtype 2 diabetes32-weekn = 120

    Effects of semaglutide and empagliflozin on markers of endothelial function in persons with type 2 diabetes: A post hoc analysis of a randomized clinical trial

    Journal of diabetes and its complications29 Aug 2026

More on Semaglutide

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 1Sep 2026: 0Oct 2026: 01 in 12 months